DK48790A - STEROID CONNECTION AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION - Google Patents

STEROID CONNECTION AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION Download PDF

Info

Publication number
DK48790A
DK48790A DK048790A DK48790A DK48790A DK 48790 A DK48790 A DK 48790A DK 048790 A DK048790 A DK 048790A DK 48790 A DK48790 A DK 48790A DK 48790 A DK48790 A DK 48790A
Authority
DK
Denmark
Prior art keywords
connection
steroid
pharmaceutical preparation
preparation containing
pharmaceutical
Prior art date
Application number
DK048790A
Other languages
Danish (da)
Other versions
DK48790D0 (en
Inventor
Kelvin W Gee
Original Assignee
Kelvin W Gee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kelvin W Gee filed Critical Kelvin W Gee
Publication of DK48790D0 publication Critical patent/DK48790D0/en
Publication of DK48790A publication Critical patent/DK48790A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK048790A 1987-08-25 1990-02-23 STEROID CONNECTION AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION DK48790A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8936287A 1987-08-25 1987-08-25
PCT/US1988/002827 WO1989002272A1 (en) 1987-08-25 1988-08-24 Compositions and methods for alleviating stress, anxiety and seizure activity

Publications (2)

Publication Number Publication Date
DK48790D0 DK48790D0 (en) 1990-02-23
DK48790A true DK48790A (en) 1990-04-25

Family

ID=22217242

Family Applications (1)

Application Number Title Priority Date Filing Date
DK048790A DK48790A (en) 1987-08-25 1990-02-23 STEROID CONNECTION AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION

Country Status (5)

Country Link
EP (1) EP0382790A4 (en)
JP (1) JPH03500049A (en)
AU (1) AU609927B2 (en)
DK (1) DK48790A (en)
WO (1) WO1989002272A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120723A (en) * 1987-08-25 1992-06-09 University Of Southern California Method, compositions, and compounds for modulating brain excitability
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5212167A (en) * 1991-09-12 1993-05-18 Trustees Of Boston University Modulation of receptor-mediated ion transport
US5795870A (en) * 1991-12-13 1998-08-18 Trustees Of Princeton University Compositions and methods for cell transformation
US5693769A (en) * 1991-12-13 1997-12-02 Transcell Technologies, Inc. Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
US5206415A (en) * 1991-12-20 1993-04-27 Washington University Tricyclic steroid analogs
DE69435286D1 (en) * 1993-05-24 2010-05-20 Purdue Pharma Ltd METHOD AND COMPOSITIONS FOR EFFECTING SLEEP
US7473687B2 (en) 2005-03-24 2009-01-06 Emory University Methods for the treatment of a traumatic central nervous system injury
EP2494976A1 (en) 2005-03-24 2012-09-05 Emory University Methods for the treatment of a traumatic central nervous system injury
CA3152410A1 (en) * 2011-10-14 2013-04-18 Sage Therapeutics, Inc. 3,3-disubstituted 19-nor pregnane compounds, compositions, and uses thereof for the treatment of cns related disorders
CA3090724A1 (en) * 2018-02-11 2019-08-15 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Steroid derivative regulators, method for preparing the same, and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE538830A (en) * 1954-10-21
FR1549153A (en) * 1962-06-15 1968-12-13
US3558673A (en) * 1966-10-29 1971-01-26 Ormonoterapia Richter Spa 10beta-amino-19-nor-pregnanes and method for the preparation thereof
DE2438020A1 (en) * 1974-08-05 1976-02-26 Schering Ag 18-METHYL-19-NOR-20-KETO-PREGNANE AND THE METHOD OF MANUFACTURING IT
FR2414514A1 (en) * 1978-01-11 1979-08-10 Roussel Uclaf NEW 17AARYL OR AHETEROARYLE STEROID DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS A MEDICINAL PRODUCT
US4273763A (en) * 1978-01-23 1981-06-16 Efamol Limited Pharmaceutical and dietary compositions
US4605649A (en) * 1983-02-22 1986-08-12 Liehr Joachim G Method of treatment of estrogen deficiency disease
FI83087C (en) * 1984-05-16 1991-05-27 Schering Ag Process for the preparation of therapeutically useful estriol-3,17-d esters

Also Published As

Publication number Publication date
EP0382790A4 (en) 1991-03-27
WO1989002272A1 (en) 1989-03-23
EP0382790A1 (en) 1990-08-22
AU2828389A (en) 1989-04-17
JPH03500049A (en) 1991-01-10
DK48790D0 (en) 1990-02-23
AU609927B2 (en) 1991-05-09

Similar Documents

Publication Publication Date Title
DK314789A (en) QUINOLINETHERALCANIC ACID AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A COMPOUND
DK85985D0 (en) CARBAMOYL OR ACYL-4-AZA-5ALFA-ANDROST-1-EN-3-ON AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH A CONNECTION
DK284485D0 (en) INDOL-2-ALKANIC ACID AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A RELATIONSHIP
DK404588D0 (en) TETRAHYDROCABAZOLE-1-ALKANIC ACID AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A COMPOUND
DK127787A (en) INTERLEUKIN-1ALFA DERIVATIVES AND MEDICINES CONTAINING SUCH DERIVATIVES
DK287085D0 (en) TRIAZOLOBENZODIAZEPINE AND PHARMACEUTICAL PREPARATION CONTAINING A SEED CONNECTION
DK655288D0 (en) DIARYLSTYRYLQUINOLINDIC ACID AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A COMPOUND
DK211689A (en) FLUORAVERMECTIN AND MILBEMYCIN COMPOUNDS AND PREPARATIONS CONTAINING SUCH A CONNECTION
DK287188A (en) CEPHALOSPOR COMPOUNDS AND PHARMACEUTICAL PREPARATIONS THEREOF
DK537288D0 (en) TETRAHYDROCARBAZOLESTES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH A CONNECTION
DK224589D0 (en) POLYMALONIC ACID COMPOUND AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION
DK48790A (en) STEROID CONNECTION AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION
DK375584A (en) PIPERIDINOQUINAZOLINE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH A CONNECTION
DK650089A (en) FURANAL CHICKETS AND PHARMACEUTICAL PREPARATIONS THEREOF
DK23088D0 (en) PIPERAZINYLPYRIMIDE CONNECTION AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION
DK191787A (en) CARBAPENNAM AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION
DK316287D0 (en) LEUKOTRIEN ANTAGONIST AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A
DK590987D0 (en) PEPTID AND PHARMACEUTICAL PREPARATION CONTAINING SUCH PEPTID
DK287185A (en) BENZODIAZEPINE DERIVATIVE AND PHARMACEUTICAL PREPARATION CONTAINING A SEED ANTI-DERIVATIVE
DK422984D0 (en) AMINOCYCLOPENTANES AND PHARMACEUTICAL PREPARATIONS THEREOF
DK258086D0 (en) SUBSTITUTED HEXAHYDROARYLQUINOLINE AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A COMPOUND
DK488688D0 (en) AZOLIDINDION DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DK151785A (en) 3-AMINOALKYLTHIO-1-PHENYLINDOL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS
DK330389D0 (en) TETRAHYDROPYRANON COMPOUND AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION
DK570988D0 (en) OR TRIPEPTIDE AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH A RELATIONSHIP

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment